Serum GP73 predicts posthepatectomy outcomes in patients with hepatocellular carcinoma

Serum GP73 predicts posthepatectomy outcomes in patients with hepatocellular carcinoma

Abstract Background and aims Serum GP73 is a useful biomarker in assessing hepatic fibrosis degree. The aim of this study was to evaluate the predictive value of serum GP73 level for posthepatectomy short-term outcomes in hepatocellular carcinoma (HCC) patients. Methods A total of 280 patients under...

Full description

Bibliographic Details
Main Authors:	Meng-yun Ke, Xiao-ning Wu, Yao Zhang, Saisai Wang, Yi Lv, Jian Dong
Format:	Article
Language:	English
Published:	BMC 2019-05-01
Series:	Journal of Translational Medicine
Subjects:	GP73 Hepatocellular carcinoma Liver fibrosis Posthepatectomy outcomes
Online Access:	http://link.springer.com/article/10.1186/s12967-019-1889-0

Similar Items

Current status of preoperative risk assessment for posthepatectomy liver failure in patients with hepatocellular carcinoma
by: Takahiro Nishio, et al.
Published: (2023-11-01)

CT-derived extracellular volume and liver volumetry can predict posthepatectomy liver failure in hepatocellular carcinoma
by: Yangling Peng, et al.
Published: (2023-09-01)

Prediction of posthepatectomy liver failure using transient elastography in patients with hepatitis B related hepatocellular carcinoma
by: Jie-wen Lei, et al.
Published: (2017-12-01)

Impact of aspartate aminotransferase–to–platelet ratio index based score to assess posthepatectomy liver failure in patients with hepatocellular carcninoma
by: Kyohei Yugawa, et al.
Published: (2022-08-01)

Nomogram for prediction of the international study Group of Liver Surgery (ISGLS) grade B/C Posthepatectomy liver failure in HBV-related hepatocellular carcinoma patients: an external validation and prospective application study
by: Jia-zhou Ye, et al.
Published: (2020-10-01)

MiR‐559 targets GP73 to suppress proliferation and invasion of hepatocellular carcinoma in vitro
by: Xue‐Song Zheng, et al.
Published: (2020-10-01)

Expression and mechanism of gp73 in liver tissue of mouse liver fibrosis
by: MA Ling-yu, ZHEN Yi-ning, LUO Yun-ping, DUAN Zhao-jun
Published: (2020-06-01)

Rapamycin inhibits colorectal cancer progression through down-regulating mTOR-GP73 pathway
by: ZHANG Meng-di, WANG Ya-nan, LI Jie, PU Yang
Published: (2020-07-01)

Whether the Golgi protein 73 could be a diagnostic serological marker in hepatocellular carcinoma: a meta analysis
by: Xu Zhang, et al.
Published: (2023-03-01)

Golgi protein 73, hepatocellular carcinoma and other types of cancers
by: Yanan Wang, et al.
Published: (2020-12-01)

Possible roles of Golgi protein-73 in liver diseases
by: Meng-Yuan Liu, et al.
Published: (2022-09-01)

PTEN deficiency potentiates HBV-associated liver cancer development through augmented GP73/GOLM1
by: Fuqiang Huang, et al.
Published: (2024-03-01)

The Ratio of Activin A and Follistatin-Like 3 Is Associated With Posthepatectomy Liver Failure and Morbidity in Patients Undergoing Liver Resection
by: Jonas Santol, et al.
Published: (2023-01-01)

A meta-analysis of the prognostic impact of tissue golgi protein 73 (tGP73) in hepatocellular carcinoma
by: Wei-Ming Yu, et al.
Published: (2023-11-01)

Hepatitis B virus promotes hepatocellular carcinoma development by activating GP73 to repress the innate immune response
by: Long Liu, et al.
Published: (2022-10-01)

Simultaneous splenectomy improving the outcomes of patients with hepatocellular carcinoma, cirrhosis and portal hypertension treated with hepatectomy
by: Fuchen Liu, et al.
Published: (2022-09-01)

Indocyanine Green Retention Test as a Predictor of Postoperative Complications in Patients with Hepatitis B Virus-Related Hepatocellular Carcinoma
by: Mai RY, et al.
Published: (2022-08-01)

Effectiveness comparison of indocyanine green retention test with the cirrhotic severity scoring in evaluating the pathological severity of liver cirrhosis in patients with hepatocellular carcinoma and Child-Pugh grade A liver function
by: Jin Gu, et al.
Published: (2020-04-01)

TAp73β Can Promote Hepatocellular Carcinoma Dedifferentiation
by: Evin Iscan, et al.
Published: (2021-02-01)

Preliminary clinical study of the safety of hepatectomy predicted by gadolinium‐ethoxybenzyl‐diethylenetriamine pentaacetic acid‐enhanced T1 mapping magnetic resonance imaging
by: Jiao Liu, et al.
Published: (2021-03-01)

Promising Outcomes of Modified ALPPS for Staged Hepatectomy in Cholangiocarcinoma
by: Arianeb Mehrabi, et al.
Published: (2023-11-01)

Golgi Protein 73 versus Alpha-Fetoprotein as a New Biomarker in Early Diagnosis of Hepatocellular Carcinoma
by: Ali OM, et al.
Published: (2020-05-01)

Clinical significance of golgi protein‐73 as a diagnostic marker for Egyptian patients with colorectal cancer: Preliminary study
by: Shaymaa Abdelraheem Abdelhady, et al.
Published: (2021-10-01)

GP73 level in patients with chronic hepatitis B: Relationship with liver biopsy, levels of ALT, AST and HBV DNA
by: Aynur Atilla, et al.
Published: (2022-01-01)

Golgi Phosphoprotein 73: The Driver of Epithelial-Mesenchymal Transition in Cancer
by: Yiming Liu, et al.
Published: (2021-12-01)

CD73 sustained cancer-stem-cell traits by promoting SOX9 expression and stability in hepatocellular carcinoma
by: Xiao-Lu Ma, et al.
Published: (2020-02-01)

Comparative study of indocyanine green (ICG)-R15 and Albumin-Indocyanine Green Evaluation (ALICE) grading system in the prediction of posthepatectomy liver failure and postoperative mortality in patients with hepatic alveolar echinococcosis
by: Yuxin Liang, et al.
Published: (2022-06-01)

Impact of Liver Fibrosis Severity on Oncological Prognosis in Hepatocellular Carcinoma
by: Koya Yasukawa, et al.
Published: (2023-10-01)

Level studies of 73As via 73Ge(p, nγ)73As reaction and density of discrete levels in 73As
by: Behkami Aziz N., et al.
Published: (2009-01-01)

Two-stage hepatectomy in resection of colorectal liver metastases – a single-institution experience with case-control matching and review of the literature
by: Turk Spela, et al.
Published: (2023-06-01)

The preoperative fibrosis score 4 predicts posthepatectomy liver failure in patients with hepatocellular carcinoma
by: Jia-Wei Feng, et al.
Published: (2019-09-01)

Serum Cartilage Oligomeric Matrix Protein and Golgi Protein-73: New Diagnostic and Predictive Tools for Liver Fibrosis and Hepatocellular Cancer?
by: Nikolaos K. Gatselis, et al.
Published: (2021-07-01)

CD73, a significant protein in liver diseases
by: Huilian Shi, et al.
Published: (2023-04-01)

CD73 promotes hepatocellular carcinoma progression and metastasis via activating PI3K/AKT signaling by inducing Rap1-mediated membrane localization of P110β and predicts poor prognosis
by: Xiao-Lu Ma, et al.
Published: (2019-04-01)

关于右GP-V-环(On right GP-V-rings)
by: YANGChun-lan(杨春兰)
Published: (2009-05-01)

Folding and Oligomerization of the gp2b/gp3/gp4 Spike Proteins of Equine Arteritis Virus in Vitro
by: Aleksander Kabatek, et al.
Published: (2012-03-01)

gp alpha Kuratowski's Closure Operators in topological spaces
by: P G Patil, et al.
Published: (2021-07-01)

Expression of the Heterotrimeric GP2/GP3/GP4 Spike of an Arterivirus in Mammalian Cells
by: Anna Karolina Matczuk, et al.
Published: (2022-04-01)

Statin Use and the Risk of Hepatocellular Carcinoma: A Meta-Analysis of Observational Studies
by: Md. Mohaimenul Islam, et al.
Published: (2020-03-01)

Mechanism study of oleanolic acid derivative, K73-03, inducing cell apoptosis in hepatocellular carcinoma
by: Jiaqi Wang, et al.
Published: (2024-01-01)